TAVRA Biosciences

Plano, United States

TAVRA Biosciences is a biotech company that offers cGMP‑manufactured stem cell products for the treatment of inflammation and injuries.

$300K raised

Apr 2026

Seed

Biotechnology Life Science Medical Pharmaceutical

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about TAVRA Biosciences

How much funding has TAVRA Biosciences raised?

TAVRA Biosciences has raised $300K in total funding. The most recent round was Seed. The last funding was announced in April 2026.

Where is TAVRA Biosciences headquartered?

TAVRA Biosciences is headquartered in Plano, United States.

What does TAVRA Biosciences do?

TAVRA Biosciences is a biotech company that offers cGMP‑manufactured stem cell products for the treatment of inflammation and injuries.

What stage is TAVRA Biosciences at?

TAVRA Biosciences is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 15, 2026.

MLA

"TAVRA Biosciences — Funding & Investors." VCBacked, April 15, 2026, https://www.vcbacked.co/company/tavra-biosciences. Accessed July 3, 2026.

APA

VCBacked. (2026). TAVRA Biosciences — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/tavra-biosciences

Wikipedia (cite web)

{{cite web |title=TAVRA Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/tavra-biosciences |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 15, 2026.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Vancouver$599K

Epsilogen

London$16.3M

Advanced Microbiome Interventions

Amsterdam$300K